LOADING
Comparing Mastercard Inc (MA) and AbbVie Inc (ABBV) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | ABBV |
|---|---|---|
| Price | $552.26 | $262.82 |
| Change Today | +0.41% | +1.11% |
| Market Cap | $481.8B | $459.3B |
| P/E Ratio | 30.3 | 74.0 |
| Forward P/E | 24.2 | 16.4 |
| PEG Ratio | 1.46 | 0.54 |
| EPS | $18.15 | $3.51 |
| Revenue Growth (YoY) | 14.1% | 10.2% |
| Profit Margin | 46.3% | 9.8% |
| Return on Equity | 241.2% | 62.3% |
| Dividend Yield | 0.61% | 2.61% |
| Beta | 0.73 | 0.28 |
| 52-Week High | $601.23 | $269.39 |
| 52-Week Low | $463.74 | $189.40 |
| Volume | 2.5M | 5.9M |
Mastercard Inc is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.